Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dacia Plant is a prominent Romanian company specializing in the development and manufacture of natural dietary supplements and phytotherapeutic remedies. Established in 2002, the company offers an extensive portfolio of over 250 products, including tablets, tinctures, syrups, and herbal teas designed to support various aspects of human health. Their formulations are developed through a blend of traditional herbal expertise and modern scientific research, often in collaboration with medical professionals. The company operates a modern production facility in Sebeș, Romania, which adheres to high quality and safety standards. In 2022, Dacia Plant was acquired by the Belgian group Ceres Pharma, a move intended to accelerate its international growth and distribution. Today, it remains one of the most trusted brands in the Romanian health and wellness sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dacia Plant.